{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:55:58Z","timestamp":1793235358687,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870067"],"award-info":[{"award-number":["81870067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170664"],"award-info":[{"award-number":["82170664"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011491","name":"Bureau of Science and Technology of Zhoushan","doi-asserted-by":"publisher","award":["2020020601012213"],"award-info":[{"award-number":["2020020601012213"]}],"id":[{"id":"10.13039\/501100011491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.trim.2022.101677","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T20:09:50Z","timestamp":1658779790000},"page":"101677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Risk factors for cytomegalovirus infection and disease after kidney transplantation: A meta-analysis"],"prefix":"10.1016","volume":"74","author":[{"given":"Yan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangqiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.trim.2022.101677_bb0005","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.transproceed.2009.07.027","article-title":"Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors[J]","volume":"41","author":"Taherimahmoudi","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2022.101677_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101473","article-title":"Cytomegalovirus infection in kidney transplant patients: prevalence, risk factors, and impact on outcome - a local multicentre experience[J]","volume":"69","author":"Abou-Jaoud\u00e9","year":"2021","journal-title":"Transpl. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2022.101677_bb0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.transproceed.2011.11.053","article-title":"Cytomegalovirus disease in kidney transplant recipients: incidence, clinical profile, and risk factors[J]","volume":"44","author":"Cordero","year":"2012","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2022.101677_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105565","article-title":"Delayed graft function and rejection are risk factors for cytomegalovirus breakthrough infection in kidney transplant recipients[J]","volume":"167","author":"Kleinherenbrink","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.trim.2022.101677_bb0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ndt\/gfz268","article-title":"Revisiting cytomegalovirus serostatus and replication as risk factors for inferior long-term outcomes in the current era of renal transplantation.[J]","volume":"35","author":"Bischof","year":"2020","journal-title":"Nephrol. Dial. Transpl.: Off. Publ. Eur. Dial. Transpl. Assoc. \u2013 Eur. Renal Assoc."},{"issue":"2","key":"10.1016\/j.trim.2022.101677_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13467","article-title":"A split strategy to prevent cytomegalovirus after kidney transplantation using prophylaxis in serological high-risk patients and a pre-emptive strategy in intermediate-risk patients: combining the best of two options?[J]","volume":"23","author":"Hellemans","year":"2021","journal-title":"Transpl. Infect. Dis."},{"issue":"8","key":"10.1016\/j.trim.2022.101677_bb0035","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/TP.0000000000000549","article-title":"Incidence, risk factors and outcomes of delayed-onset cytomegalovirus disease in a large retrospective cohort of lung transplant recipients.[J]","volume":"99","author":"Santos","year":"2015","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.trim.2022.101677_bb0040","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort study","volume":"71","author":"van Delden","year":"2020","journal-title":"Clin. Infect. Diseases: Off. Publ. Infect. Diseases Soc. Am."},{"issue":"01","key":"10.1016\/j.trim.2022.101677_bb0045","first-page":"115","article-title":"Research progress on prevention and treatment of donor-derived infection in organ transplantation[J]","volume":"11","author":"Xuxia","year":"2020","journal-title":"Organ Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2022.101677_bb0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5935\/0101-2800.20170074","article-title":"The current burden of cytomegalovirus infection in kidney transplant recipients receiving no pharmacological prophylaxis[J]","volume":"39","author":"Felipe","year":"2017","journal-title":"J. Bras. Nefrol"},{"issue":"6","key":"10.1016\/j.trim.2022.101677_bb0055","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1399-3062.2012.00759.x","article-title":"Cytomegalovirus disease in African-American kidney transplant patients[J]","volume":"14","author":"Mcgee","year":"2012","journal-title":"Transpl. Infect. Dis."},{"issue":"6","key":"10.1016\/j.trim.2022.101677_bb0060","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.transproceed.2009.06.057","article-title":"Cytomegalovirus infection renal transplant recipients: risk factors and outcome[J]","volume":"41","author":"Kanter","year":"2009","journal-title":"Transplant. Proc."},{"issue":"10","key":"10.1016\/j.trim.2022.101677_bb0065","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1016\/j.transproceed.2020.03.023","article-title":"Cytomegalovirus experience in pediatric kidney transplantation in 26 Years\u2019 time[J]","volume":"52","author":"Keskinoglu","year":"2020","journal-title":"Transplant. Proc."},{"issue":"7","key":"10.1016\/j.trim.2022.101677_bb0070","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.transproceed.2021.07.033","article-title":"Clinical characteristics of late-onset cytomegalovirus infection after kidney transplantation[J]","volume":"53","author":"Nuansri","year":"2021","journal-title":"Transplant. Proc."},{"issue":"3","key":"10.1016\/j.trim.2022.101677_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10096-019-03744-3","article-title":"Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus-positive kidney transplant recipient[J]","volume":"39","author":"Hemmersbach-Miller","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"6","key":"10.1016\/j.trim.2022.101677_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3851\/IMP3129","article-title":"The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation[J]","volume":"22","author":"Reischig","year":"2017","journal-title":"Antivir. Ther."},{"issue":"1","key":"10.1016\/j.trim.2022.101677_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171035","article-title":"Primary cytomegalovirus infection in seronegative kidney transplant patients is associated with protracted cold ischemic time of seropositive donor organs[J]","volume":"12","author":"Schlott","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.trim.2022.101677_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-guidelines of the American Society of Transplantation infectious diseases Community of Practice[J]","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin. Transpl."},{"issue":"Suppl. 4","key":"10.1016\/j.trim.2022.101677_bb0095","article-title":"Cytomegalovirus in solid organ transplant recipients.[J]. American journal of transplantation: official journal of the American Society of Transplantation and the","volume":"9","author":"Humar","year":"2009","journal-title":"Am. Soc. Transpl. Surg."},{"issue":"8","key":"10.1016\/j.trim.2022.101677_bb0100","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients[J]","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"26","key":"10.1016\/j.trim.2022.101677_bb0105","article-title":"A suggestion for quality assessment in systematic reviews of observational studies in nutritional epidemiology[J]","volume":"38","author":"Jm","year":"2016","journal-title":"Epidemiol. Health"},{"issue":"9","key":"10.1016\/j.trim.2022.101677_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.[J]","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.trim.2022.101677_bb0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/ijms20030546","article-title":"Killer immunoglobulin-like receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as genetic markers for stratifying the risk of cytomegalovirus infection in kidney transplant recipients[J]","volume":"20","author":"Deborska-Materkowska","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.trim.2022.101677_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13106","article-title":"Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy[J]","volume":"21","author":"Felipe","year":"2019","journal-title":"Transpl. Infect. Dis."},{"issue":"2","key":"10.1016\/j.trim.2022.101677_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13035","article-title":"Late cytomegalovirus (CMV) infections after kidney transplantation under the preemptive strategy: risk factors and clinical aspects[J]","volume":"21","author":"Ono","year":"2019","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2022.101677_bb0130","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.3389\/fimmu.2019.02871","article-title":"The aquaporin 5 -1364A\/C promoter polymorphism is associated with cytomegalovirus infection risk in kidney transplant recipients[J]","volume":"10","author":"Rahmel","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2022.101677_bb0135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12879-018-3075-z","article-title":"Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients[J]","volume":"18","author":"Deborska-Materkowska","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"8","key":"10.1016\/j.trim.2022.101677_bb0140","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.transproceed.2016.08.015","article-title":"Incidence and risk factors for cytomegalovirus infection in patients with kidney transplantation: a single-center experience[J]","volume":"48","author":"Feng","year":"2016","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.trim.2022.101677_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/tid.12494","article-title":"Fewer cytomegalovirus complications after kidney transplantation by de novo use of mTOR inhibitors in comparison to mycophenolic acid[J]","volume":"18","author":"Radtke","year":"2016","journal-title":"Transpl. Infect. Dis."},{"issue":"8","key":"10.1016\/j.trim.2022.101677_bb0150","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.transproceed.2015.08.011","article-title":"Risk factors of cytomegalovirus disease in kidney transplant recipients: a single-center study in Thailand[J]","volume":"47","author":"Chiasakul","year":"2015","journal-title":"Transplant. Proc."},{"issue":"6","key":"10.1016\/j.trim.2022.101677_bb0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/tid.12133","article-title":"Critical analysis of valganciclovir dosing and renal function on the development of cytomegalovirus infection in kidney transplantation[J]","volume":"15","author":"Posadas","year":"2013","journal-title":"Transpl. Infect. Dis."},{"issue":"02","key":"10.1016\/j.trim.2022.101677_bb0160","first-page":"79","article-title":"Risk factors of cytomegalovirus infection and the predictive value of mannose-binding lectin after renal transplantation[J]","volume":"4","author":"Jimin","year":"2013","journal-title":"Organ Transplantation"},{"issue":"3","key":"10.1016\/j.trim.2022.101677_bb0165","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.transproceed.2011.12.029","article-title":"Cytomegalovirus viremia after kidney transplantation in Thailand: predictors of symptomatic infection and outcome[J]","volume":"44","author":"Watcharananan","year":"2012","journal-title":"Transplant. Proc."},{"issue":"4","key":"10.1016\/j.trim.2022.101677_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13577","article-title":"The burden of cytomegalovirus infection remains high in high-risk kidney transplant recipients despite six-month valganciclovir prophylaxis[J]","volume":"23","author":"R\u00e4ih\u00e4","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.trim.2022.101677_bb0175","first-page":"315","article-title":"Impact of cytomegalovirus infection on recipients of kidney transplantation and its risk factors[J]","volume":"05","author":"Chen","year":"2008","journal-title":"Chin. J. Nephrol."},{"issue":"03","key":"10.1016\/j.trim.2022.101677_bb0180","first-page":"192","article-title":"Analyses for clinical characteristics and risk factors of cytomegalovirus pneumonia after renal transplantation[J]","volume":"6","author":"Tieyan","year":"2018","journal-title":"Prac. J. Organ Transplant."},{"issue":"1","key":"10.1016\/j.trim.2022.101677_bb0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.transproceed.2017.12.025","article-title":"Prevention of late-onset cytomegalovirus infection and disease in donor-positive\/recipient-negative kidney transplant recipients using low-dose Valganciclovir[J]","volume":"50","author":"Nanmoku","year":"2018","journal-title":"Transplant. Proc."},{"issue":"3","key":"10.1016\/j.trim.2022.101677_bb0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.15171\/jnp.2017.39","article-title":"Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study.[J]","volume":"6","author":"Navarro-Rodr\u00edguez","year":"2017","journal-title":"J. Nephropathol."},{"issue":"3","key":"10.1016\/j.trim.2022.101677_bb0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/tid.12226","article-title":"Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+\/R-): experience from the RESITRA-REIPI cohort[J]","volume":"16","author":"Meije","year":"2014","journal-title":"Transpl. Infect. Dis."},{"issue":"2","key":"10.1016\/j.trim.2022.101677_bb0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/TP.0000000000000030","article-title":"Delayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation[J]","volume":"98","author":"Santos","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2022.101677_bb0205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.transproceed.2013.07.070","article-title":"Incidence and risk factors for cytomegalovirus disease in a Colombian cohort of kidney transplant recipients[J]","volume":"46","author":"D\u00edaz","year":"2014","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2022.101677_bb0210","first-page":"705","article-title":"Risk factors for cytomegalovirus pneumonia after kidney transplantation[J]","volume":"11","author":"Hua","year":"2006","journal-title":"Chin. J. Nephrol."},{"issue":"6","key":"10.1016\/j.trim.2022.101677_bb0215","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1047-2797(01)00283-6","article-title":"Hospitalizations for cytomegalovirus disease after renal transplantation in the United States[J]","volume":"12","author":"Kevin","year":"2002","journal-title":"Ann. Epidemiol."},{"issue":"1","key":"10.1016\/j.trim.2022.101677_bb0220","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/jmg.2009.068841","article-title":"Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation[J]","volume":"47","author":"Hoffmann","year":"2010","journal-title":"J. Med. Genet."},{"issue":"7","key":"10.1016\/j.trim.2022.101677_bb0225","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1111\/ajt.16430","article-title":"Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept[J]","volume":"21","author":"Chavarot","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2022.101677_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival[J]","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.trim.2022.101677_bb0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/tid.12408","article-title":"Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome[J]","volume":"17","author":"Viot","year":"2015","journal-title":"Transpl. Infect. Dis."},{"issue":"1","key":"10.1016\/j.trim.2022.101677_bb0240","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.transproceed.2012.04.036","article-title":"Six-month low-dose valganciclovir prophylaxis in cytomegalovirus D+\/R- kidney transplant patients receiving thymoglobulin induction[J]","volume":"45","author":"Luan","year":"2013","journal-title":"Transplant. Proc."},{"issue":"6","key":"10.1016\/j.trim.2022.101677_bb0245","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijid.2021.04.032","article-title":"Cytomegalovirus in renal transplant recipients from living donors with and without valganciclovir prophylaxis and with immunosuppression based on anti-thymocyte globulin or basiliximab[J]","volume":"107","author":"Andrade-Sierra","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.trim.2022.101677_bb0250","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.transproceed.2006.07.001","article-title":"Cytomegalovirus prophylaxis with intravenous polyvalent immunoglobulin in high-risk renal transplant recipients[J]","volume":"38","author":"Leroy","year":"2006","journal-title":"Transplant. Proc."},{"issue":"8","key":"10.1016\/j.trim.2022.101677_bb0255","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/10898540-000000000-00000","article-title":"New developments in the management of cytomegalovirus infection after solid organ transplantation.[J]","volume":"70","author":"Eid","year":"2010","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.trim.2022.101677_bb0260","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease[J]","volume":"3","author":"Kato","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.trim.2022.101677_bb0265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1517\/14740338.2014.905540","article-title":"Do we need to worry about mycophenolate overdose?[J]","volume":"13","author":"Filler","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.trim.2022.101677_bb0270","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12929","article-title":"Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: outcome and risk factors for late CMV disease.[J]","volume":"20","author":"Reusing","year":"2018","journal-title":"Transpl. Infect. Dis.: Off. J. Transplant. Soc."},{"issue":"11","key":"10.1016\/j.trim.2022.101677_bb0275","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/14740338.2019.1662787","article-title":"Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation[J]","volume":"18","author":"El","year":"2019","journal-title":"Expert Opin. Drug Saf."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327422001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:03:56Z","timestamp":1760810636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327422001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":55,"alternative-id":["S0966327422001514"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2022.101677","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for cytomegalovirus infection and disease after kidney transplantation: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2022.101677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101677"}}